Cite
HARVARD Citation
Arcari, A. et al. (2019). Corrigendum to "Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature" [Leukemia Res. Rep. 8 (2017) 21–23]. Leukemia research reports. pp. 51-. [Online].